Retatrutide is a newly developed therapy that acts as a strong GLP-1 receptor agonist. This innovative treatment holds significant promise for controlling type 2 diabetes. By mimicking the actions of natural GLP-1, https://woodytgsm559340.anchor-blog.com/19530270/retatrudiate-a-novel-glp-1-receptor-agonist-for-diabetes-management